The role of WT1 in breast cancer: clinical implications, biological effects and molecular mechanism

被引：36

作者：

Zhang, Ye ^{[1
]}

Yan, Wen-Ting ^{[1
]}

Yang, Ze-Yu ^{[2
]}

Li, Yan-Ling ^{[1
]}

Tan, Xuan-Ni ^{[1
]}

Jiang, Jun ^{[1
]}

Zhang, Yi ^{[1
]}

Qi, Xiao-Wei ^{[1
]}

机构：

[1] Army Med Univ, Southwest Hosp, Breast & Thyroid Surg, Gaotanyan St 29, Chongqing 400038, Peoples R China

[2] Univ Chinese Acad Sci, Chongqing Gen Hosp, Breast & Thyroid Surg, Chongqing 400013, Peoples R China

来源：

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES | 2020年 / 16卷 / 08期

基金：

中国国家自然科学基金;

关键词：

WT1; breast neoplasms; prognosis; carcinogenesis; TUMOR SUPPRESSOR GENE; ESTROGEN-RECEPTOR-ALPHA; TRANSCRIPTIONAL REGULATION; WILMS-TUMOR-1; PROTEIN; DOWN-REGULATION; POOR-PROGNOSIS; EXPRESSION; ISOFORMS; GROWTH; PROLIFERATION;

D O I：

10.7150/ijbs.39958

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Although Wilms' tumor gene 1 (WT1) was first cloned and identified as a tumor suppressor gene in nephroblastoma, subsequent studies have demonstrated that it can also play an oncogenic role in leukemia and various solid tumors. WT1 exerts biological functions with high tissue- and cell-specificity. This article reviews the relationship between WT1 and breast cancer from two aspects: (1) clinical application of WT1, including the relationship between expression of WT1 and prognosis of breast cancer patients, and its effectiveness as a target for comprehensive therapy of breast cancer; (2) the biological effects and molecular mechanisms of WT1 in the development and progression of breast cancer, including proliferation, apoptosis, invasion, and metastasis of breast cancer cells.

引用

页码：1474 / 1480

页数：7

共 50 条

[21] The Wilms tumor gene product (WT1) is not expressed in human breast epithelium or breast cancer
Gown, AM
Yaziji, H
Ellis, GK
Livingston, RB
MODERN PATHOLOGY, 2003, 16 (01) : 31A - 31A
[22] Identifying a role for WT1 in pediatric leukemia
Moazam, M. M.
Eisermann, K.
Fraizer, G.
Kuerbitz, S. J.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[23] ROLE OF WT1 IN JUVENILE MYELOMONOCYTIC LEUKEMIA
de Vries, A.
Zwaan, C.
Bader, P.
Willasch, A.
Aalders, M.
Haas, O.
de Haas, V.
Niemeyer, C.
van den Heuvel-Eibrink, M.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 559 - 559
[24] Cancer Immunotherapy Targeting WT1 Protein
Haruo Sugiyama
International Journal of Hematology, 2002, 76 : 127 - 132
[25] WT1 and Wnt Signaling in Prostate Cancer
Brett, Adina
Eisermann, Kurtis
Reese, Jennifer
Fraizer, Gail
BIOLOGY OF REPRODUCTION, 2009, : 127 - 127
[26] Cancer immunotherapy targeting WT1 protein
Sugiyama, H
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 76 (02) : 127 - 132
[27] WT1 peptide vaccine for the treatment of cancer
Oka, Yoshihiro
Tsuboi, Akihiro
Oji, Yusuke
Kawase, Ichiro
Sugiyama, Haruo
CURRENT OPINION IN IMMUNOLOGY, 2008, 20 (02) : 211 - 220
[28] WT1 as a target for immunotherapy inovarian cancer
Ghaem-Maghami, S
Nikolakopoulou, Z
Gabra, H
Stauss, H
IMMUNOLOGY, 2005, 116 : 40 - 40
[29] Microarray-predicted molecular effect of WT1 isoforms in MCF-7 breast cancer cell line
Kanokwiroon, K.
Eros, K.
Graidist, P.
Nakatake, A.
Morishita, K.
FEBS OPEN BIO, 2019, 9 : 333 - 333
[30] Correlation of Wilms’ Tumor 1 (WT1) with Oxidative Stress Markers and Expression of miR-361-5p; New Aspect of WT1 in Breast Cancer
Fariba Pishbin
Nasrin Ziamajidi
Roghayeh Abbasalipourkabir
Rezvan Najafi
Maryam Farhadian
Indian Journal of Clinical Biochemistry, 2023, 38 : 338 - 350

← 1 2 3 4 5 →